Pulmonary embolism, coagulation

Version vom 28. Juni 2020, 20:26 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Since there are many organ manifestations of Hypercoagulation, subcategorization and transcategorization was applied.

• Venous thrombosis
• Pulmonary embolism
• Cerebral embolism
• Myocardial infarction
• Arterial embolism
• Microembolism
• Hypercoagulation
• Antiphospholipid antibodies
• Disseminated intravascular coagulation
• Bleeding
• Labwork of Thrombembolism
• Prophylaxis of Thrombembolism

The unifying concept behind is Dysendotheliopathies with the components Coagulation /Microthrombi, proliferative or cytopathic obstructive Endotheliosis and mediator production as well as failure of the mitigating systems and secondary vasculitis.

• papers on various thromboembolic manifestations

32281926 2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
32347323 ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
32360371 ä. Thromboembolic events in patients with SARS-CoV-2
C7146714 ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
32324101 2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
32133825 2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19
32402423 2020. Ten key points that vascular doctors learned very quickly about COVID-19
32381264 2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
32388068 2020. Thrombotic complications in critically ill patients with COVID 19
32291094 2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
32374544 2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives

• thrombotic late reactions

• papers on Hypoxemia

32359410 ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
C7177114 2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
32376101 2020. Association Between Hypoxemia and Mortality in Patients With COVID-19

• others

32462990 2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.
32338320 ä. Covid-19 treatment update: follow the scientific evidence
32501145 2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
32459857 2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
32314950 2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.
32447301 2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.
32455440 2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
32396963 2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
32512587 2020. Bleeding and Bleeding Risk in COVID-19.
32463186 2020. Lungeembolisme ved covid-19.
32425013 2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
32469410 2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
32392741 2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
32447934 2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
32395964 2020. Do's-and-don'ts bij COVID-19-coagulopathie.
32454268 2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.
32507399 2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.
32380898 2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.
32490886 2020. Is there a rationale for heparin use among severe COVID-19 patients?
32453702 2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.
32427809 2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.
32426897 2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.
32415902 2020. Ibuprofen and thromboembolism in SARS-COV2.
32506364 2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
32504449 2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
32464707 2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.
32470213 2020. All those D-dimers in COVID-19.
32470207 2020. Frequency of lupus anticoagulant in Covid-19 patients.
32470198 2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.
32470154 2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.
32470156 2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
32393875 2020. Coronavirus blood-clot mystery intensifies.
32497287 2020. Anticardiolipin antibodies and COVID-19-A case report from America.
32495985 2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.
32409435 2020. Coagulopathy in COVID-19.
32505779 2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
32512349 2020. Clinically significant anticardiolipin antibodies associated with COVID-19.
32468942 2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
32464676 2020. Haemostasis in Times of COVID-19.
32498097 2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
32476551 2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?
32429774 2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
32508034 2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.

32432563 2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.
32421381 2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.
32412320 2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.
32508261 2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.
32463538 2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.
32406381 2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.
32423903 2020. Thrombotic risk in COVID-19: a case series and case-control study.
32491074 2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.
32396903 2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
32500589 2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.

32503799 2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.
32452757 2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?
32512408 2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.
32453688 2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.
32438458 2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.

32420615 2020. Dynamic relationship between D-dimer and COVID-19 severity.
32510975 2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?
32383969 2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.
32478611 2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".
32506683 2020. D-dimer triage for COVID-19.
32484901 2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
32497248 2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.
32484907 2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.
32420614 2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.
32439704 2020. Covid-19 and thrombosis: what do we know about the risks and treatment?
32462179 2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
32492712 2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.